ATP‐binding cassette superfamily transporter gene expression in human soft tissue sarcomas
Authors:
Open Access
- 17 December 2004
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 114 (6) , 854-862
Abstract
The phenomenon of multidrug resistance (MDR) in various malignant neoplasms has been reported as being caused by one or multiple expressions of ATP‐binding cassette (ABC) superfamily protein, including P‐glycoprotein/multidrug resistance (MDR) 1 and the MDR protein (MRP) family. However, their expression levels and distribution within soft tissue sarcomas remain controversial. In 86 cases of surgically resected soft tissue sarcoma, intrinsic mRNA levels of MDR1, MRP1, MRP2 and MRP3 were assessed using a quantitative reverse transcriptase‐PCR (RT‐PCR) method. Moreover, immunohistochemical protein expressions of P‐glycoprotein (P‐gp), MRP1, MRP2, MRP3 and p53 protein were evaluated in concordant paraffin‐embedded material. The mRNA expression and immunohistochemical expression of ABC superfamily transporters were compared to clinicopathologic parameters and proliferative activities as evaluated by the MIB‐1‐labeling index (LI). Among the various histologic types, malignant peripheral nerve sheath tumor (MPNST) showed significantly high levels of MDR1 (p=0.017) and MRP3 (p=0.0384) mRNA expression, compared to the other tumor types. When the immunohistochemical method was compared to the RT‐PCR technique to assess ABC transported expression at the protein and mRNA levels, a significantly close relationship was found between the 2 methods (pp=0.041) and high AJCC stage (stages III and IV) (p=0.0365). Furthermore, cases with nuclear expression of p53 revealed significantly higher levels of MDR1 mRNA expression, compared to those with negative immunoreaction for p53 (p=0.0328). Our results suggest that MDR1/P‐gp expression may have an important role to play in tumor progression in the cases of soft tissue sarcoma, and p53 may be one of the active regulators of the MDR1 transcript. In addition, the high levels of both MDR1 and MRP3 mRNA expression in MPNST may help to explain the poor response of this tumor to anticancer‐drugs.Keywords
This publication has 38 references indexed in Scilit:
- The multidrug resistance-associated protein 3 (MRP3) is associated with a poor outcome in childhood ALL and may account for the worse prognosis in male patients and T-cell immunophenotypeBlood, 2003
- Nuclear expression of Y‐box‐binding protein‐1 correlates with P‐glycoprotein and topoisomerase II alpha expression, and with poor prognosis in synovial sarcomaThe Journal of Pathology, 2003
- Hyperthermia-induced Nuclear Translocation of Transcription Factor YB-1 Leads to Enhanced Expression of Multidrug Resistance-related ABC TransportersJournal of Biological Chemistry, 2001
- Regulation of expression of the multidrug resistance protein MRP1 by p53 in human prostate cancer cellsJournal of Clinical Investigation, 2000
- MDR1 expression correlates with mutantp53 expression in colorectal cancer metastasesJournal of Cancer Research and Clinical Oncology, 1996
- Reverse Transcriptase-Polymerase Chain Reaction Amplification of MDR1 Gene Expression in Adult Soft Tissue SarcomasDiagnostic Molecular Pathology, 1996
- Biology of the multidrug resistance-associated protein, MRPEuropean Journal of Cancer, 1996
- Cancer statistics, 1996CA: A Cancer Journal for Clinicians, 1996
- Expression of the mdr1 gene in bone and soft tissue sarcomas of adult patientsEuropean Journal of Cancer, 1993
- BIOCHEMISTRY OF MULTIDRUG RESISTANCE MEDIATED BY THE MULTIDRUG TRANSPORTERAnnual Review of Biochemistry, 1993